Opinion: Trump's encrypted strategic reserves guide the market to rebuild long positions, which may drive prices up

ADS agreed to buy StormTrap Investments from PSP Capital for about $530 million, or about $450 million adjusted for expected tax benefits. Deal expands ADS into large-volume, space-constrained stormwater storage and treatment systems, strengthening its offering in commercial and infrastructure projects. StormTrap posted about $165 million revenue, about $40 million adjusted EBITDA for the 12 months ended July 2026. Net valuation implies about 10x adjusted EBITDA, including expected run-rate cost synergies; funding set from cash and existing credit lines. Closing targeted for the fourth quarter of calendar 2026, subject to customary closing conditions and required regulatory approvals. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADS - Advanced Drainage Systems Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610050645BIZWIRE_USPR_____20261005_BW997833) on October 05, 2026, and is solely responsible for the information contained therein.

October 5 – Vaxcyte (PCVX.O) shares surged 26% pre-market to $71.17. Vaxcyte announced that its 31-valent pneumococcal vaccine VAX-31 met all primary endpoints in a late-stage clinical trial, and generated immune responses comparable to or stronger than Pfizer’s Prevnar 20 and Merck’s Capvaxive. The safety and tolerability of the vaccine were similar to existing vaccines. Vaxcyte expects results from two additional late-stage clinical trials in the first half of 2027, and plans to submit a marketing application to the FDA in the first half of 2028. As of the previous trading session’s close, the stock had risen 22.4% year-to-date.

Linde will publish third-quarter 2026 results on Oct. 29, 2026 by 6:00 a.m. EDT (11:00 a.m. CET). Conference call webcast set for Oct. 29, 2026 at 9:00 a.m. EDT (2:00 p.m. CET). Web replay available from Oct. 29, 2026 at 10:30 a.m. EDT (3:30 p.m. CET) via https://www.linde.com/investors/financial-reports. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Linde plc published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2409690_en) on October 05, 2026, and is solely responsible for the information contained therein.